1. Eucannabinolide, a novel sesquiterpene lactone, suppresses the growth, metastasis and BCSCS-like traits of TNBC via inactivation of STAT3
- Author
-
Huajun Zhao, Bo Yang, Zhihui Zhu, Yingying Wei, Jingtao Yuan, and Xintong Xu
- Subjects
0301 basic medicine ,Cancer Research ,Eucannabinolide ,Proliferation ,Luc, luciferase ,Apoptosis ,Triple Negative Breast Neoplasms ,Sesquiterpene lactone ,EMSA, Electrophoretic mobility shift assay ,Metastasis ,STAT3 ,Lactones ,Mice ,0302 clinical medicine ,bFGF, basic fibroblast growth factor ,Triple negative breast cancer ,Neoplasm Metastasis ,Cytotoxicity ,Triple-negative breast cancer ,TNBC, triple negative breast cancer ,Original Research ,chemistry.chemical_classification ,biology ,Chemistry ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Breast cancer stem cells ,hEGF, human epidermal growth factor ,030220 oncology & carcinogenesis ,Caspases ,Neoplastic Stem Cells ,Cytokines ,Female ,Sesquiterpenes ,Signal Transduction ,STAT3 Transcription Factor ,DEAB, Diethylamino-benzaldehyde ,DMSO, dimethylsulfoxide ,Cell Survival ,BCSCs, breast cancer stem cells ,Tyr705, tyrosine 705 ,lcsh:RC254-282 ,Euc, Eucannabinolide ,DMEM, Dulbecco's Modified Eagle's Medium ,03 medical and health sciences ,FBS, fetal bovine serum ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Viability assay ,Cell Proliferation ,Neoplasm Staging ,Interleukin-6 ,Cancer ,medicine.disease ,DOX, doxorubicin ,STAT3, Signal transducer and activator of transcription 3 ,Disease Models, Animal ,030104 developmental biology ,Cancer research ,STAT protein ,biology.protein ,BSA, Bovine Serum Albumin - Abstract
Highlights • Euc decreased expression of p-STAT3 (Tyr705), nuclear translocation and DNA-binding. • Euc inhibited cell viability, metastasis and BCSC-like traits by inhibiting STAT3. • Euc covalently interacted with STAT3 through a Michael addition reaction. • Euc exhibits potent anti-tumor growth and lung metastasis without acute toxicity., Signal transducer and activator of transcription 3 (STAT3) is an important therapeutic target to triple negative breast cancer (TNBC) treatment. In the present study, we aim to investigate the potential activity of Eucannabinolide (Euc), a novel sesquiterpene lactone separated from Eupatorium cannabinum Linn. against TNBC by targeting STAT3 and expect that Euc will be developed as an inhibitor of STAT3 in the treatment of TNBC. We found that Euc effectively suppressed STAT3 activation at tyrosine 705, inhibited its translocation to nucleus, and decreased its DNA binding capacity. Moreover, introduction of STAT3-short hairpin RNAs or STAT3 inhibitor S3I-201 attenuates the Euc-induced inhibition of cell viability. And, Euc inhibited cell viability, proliferation, metastasis and breast cancer stem cell-like traits but did not induce cytotoxicity in human mammary epithelial cells. The in vivo study similarly demonstrated that administration of Euc inhibited the growth of xenograft tumors and impaired tumor metastasis of a lung metastasis model. The above phenomena were associated with STAT3 dysfunction induced by Euc. In conclusion, Euc elicits the effects of anti-proliferation, anti-metastasis and anti-breast cancer stem cell-like traits in TNBC via targeting STAT3. These data highlight that development of Euc as a STAT3 inhibitor may offer a promising therapeutic strategy for TNBC.
- Published
- 2021